scholarly article | Q13442814 |
P2093 | author name string | E A Sausville | |
P M Blumberg | |||
M G Kazanietz | |||
P J Worland | |||
C M Seynaeve | |||
P433 | issue | 6 | |
P304 | page(s) | 1207-1214 | |
P577 | publication date | 1994-06-01 | |
P1433 | published in | Molecular Pharmacology | Q1943386 |
P1476 | title | Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue | |
P478 | volume | 45 |
Q36623957 | Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines |
Q37168650 | CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors |
Q28250447 | Cell cycle kinases as therapeutic targets for cancer |
Q35921522 | Cellular pharmacology of protein kinase Mζ (PKMζ) contrasts with its in vitro profile: implications for PKMζ as a mediator of memory |
Q35867102 | Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling. |
Q30393891 | Comprehensive Structural and Functional Characterization of the Human Kinome by Protein Structure Modeling and Ligand Virtual Screening |
Q28609845 | Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase |
Q34670556 | Endothelial protein kinase C isoform identity and differential activity of PKCzeta in an athero-susceptible region of porcine aorta |
Q44620620 | Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition |
Q30306742 | Intracellular signals that control cell proliferation in mammalian balance epithelia: key roles for phosphatidylinositol-3 kinase, mammalian target of rapamycin, and S6 kinases in preference to calcium, protein kinase C, and mitogen-activated [...] |
Q38834586 | Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease |
Q34464422 | Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection |
Q41175743 | Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). |
Q36614208 | Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01 |
Q38171231 | Protein kinase C and cancer: what we know and what we do not. |
Q39098659 | Protein kinase C in cancer: The top five unanswered questions. |
Q40815555 | Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion |
Q34457430 | Protein kinase C inhibitors |
Q38105600 | Protein kinase C pharmacology: refining the toolbox |
Q33969238 | Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. |
Q33982554 | Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes |
Q38168080 | Side-effects of protein kinase inhibitors on ion channels |
Q54242951 | Staurosporine induces chondrogenesis of chick embryo wing bud mesenchyme in monolayer cultures through canonical and non-canonical TGF-β pathways. |
Q39249805 | Staurosporines disrupt phosphatidylserine trafficking and mislocalize Ras proteins. |
Q27024068 | The Novel PKCθ from Benchtop to Clinic |
Q28485896 | Two 4N cell-cycle arrests contribute to cisplatin-resistance |
Q35082212 | Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation |
Search more.